Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by tickle1ston Apr 13, 2014 10:26pm

157 Views

Post# 22446141

RE:RE:RE:RE:RE:RE:Dilution

Stocker idiot..So you think stock dilution is just fine eh. I don't like it at all. I hate consolidation even more after they pump so much paper on the street that they got to whack shareholders again.

By the time we get to $50 or so, unless you keep buying stock and after all the consolidations your probaly going to see, you're still going to endup with squat for holdings. Why? Because you don't have all these cheap options to fall back on.

i stand by my post.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features